MedPage Today - "Test May Suggest Tysabri for More MS Patients"

New York
 – October 7, 2013 /Press Release/  –– 

A study that is testing blood for L-selectin expression on circulating immune cells may identify multiple sclerosis (MS) patients who could safely receive natalizumab (Tysabri), a prescription drug used to treat Crohn's disease, despite past exposure to the JC virus. Session co-moderator, Fred Lublin, MD, of the Icahn School of Medicine at Mount Sinai,, told MedPage Today that it was too early to say how much promise the technology held. "There is not enough data," Dr. Lublin said.
Learn more